Shanghai Haohai Biological Technology Co's quarterly market cap
declined
from Sep. 2025 (¥11,876 Mil) to Dec. 2025 (¥9,927 Mil) and
declined
from Dec. 2025 (¥9,927 Mil) to Mar. 2026 (¥8,753 Mil).
Shanghai Haohai Biological Technology Co's annual market cap
declined
from Dec. 2023 (¥18,569 Mil) to Dec. 2024 (¥13,963 Mil) and
declined
from Dec. 2024 (¥13,963 Mil) to Dec. 2025 (¥9,927 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shanghai Haohai Biological Technology Co's Enterprise Value for Today is ¥4,544 Mil.
Shanghai Haohai Biological Technology Co (SHSE:688366) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Shanghai Haohai Biological Technology Co Market Cap Related Terms
Shanghai Haohai Biological Technology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haohai Biological Technology Co Market Cap Chart
Shanghai Haohai Biological Technology Co Annual Data
SHSE:688366 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Haohai Biological Technology Co Market Cap vs Biotechnology Industry
Shanghai Haohai Biological Technology Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haohai Biological Technology Co (SHSE:688366) has a Market Cap of ¥6,320 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shanghai Haohai Biological Technology Co and its competitors. According to the industry distribution chart, Shanghai Haohai Biological Technology Co ranks #306 out of 1428 companies in the Biotechnology industry, placing it in the top 21.4%.
Is Shanghai Haohai Biological Technology Co's Market Cap too high?
Shanghai Haohai Biological Technology Co's current Market Cap is ¥6,320 Mil. Based on the distribution chart, Shanghai Haohai Biological Technology Co ranks #306 out of 1428 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Haohai Biological Technology Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haohai Biological Technology Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Haohai Biological Technology Co ranks #306 out of 1428 companies for Market Cap. This places Shanghai Haohai Biological Technology Co in the top 21% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.44, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shanghai Haohai Biological Technology Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Haohai Biological Technology Co's current Market Cap is ¥6,320 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haohai Biological Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co (SHSE:688366) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥40.81, compared to a current price of ¥30.65 — trading 24.9% below its estimated fair value. The current Market Cap is ¥6,320 Mil. Shanghai Haohai Biological Technology Co's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Shanghai Haohai Biological Technology Co (SHSE:688366), the current Market Cap is ¥6,320 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Haohai Biological Technology Co (SHSE:688366) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co stock appears to be undervalued.
The current stock price of ¥30.65 is trading 24.9% below its estimated GF Value™ of ¥40.81.
GuruFocus considers Shanghai Haohai Biological Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688366:
Market Cap: ¥6,320 Mil
GF Value™: ¥40.81 vs. price of ¥30.65 (24.9% below fair value)
No single metric tells the full story. See the SHSE:688366 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Haohai Biological Technology Co Business Description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
73GF Score
Get the complete analysis for SHSE:688366
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688366 has been successfully added to your 
